| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 05/07/2026 | ±2.0% | -2.2% | under-priced |
| 02/26/2026 | ±1.8% | +0.7% | over-priced |
| 11/05/2025 | ±1.7% | -0.1% | over-priced |
| 08/07/2025 | ±2.4% | +1.8% | over-priced |
| 05/08/2025 | ±2.0% | -0.1% | over-priced |
| 02/25/2025 | ±1.6% | -19.0% | under-priced |
| 11/06/2024 | ±2.2% | +7.3% | under-priced |
| 08/06/2024 | ±2.6% | -2.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.58 | $3.4B | $1.0B |
| Q4 FY2025 | — | $4.6B | $352M |
| Q3 FY2025 | $0.12 | $2.8B | $95M |
| Q2 FY2025 | $0.71 | $2.7B | $473M |
SRE (SRE) reports in 7 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 4.2% on average — the market has been roughly fair on SRE's earnings risk. Fundamentals into the print: EPS up 13.7% year-over-year, revenue down 6.9%. QuantLogix's live 5-factor engine currently reads SRE as a neutral at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →